Diabetes · 2004 · 19 citations · 49 references
MedicineEndocrinologyHematologyDiabetologyHemostasisKidney TransplantationDiabetes MellitusPancreas TransplantationPlatelet ActivationPlatelet DisordersPlatelet FunctionPlatelet Physiology
To evaluate the effects of kidney-pancreas transplantation on hemostatic abnormalities in uremic type 1 diabetic patients, we conducted a cross-sectional study involving 12 type 1 diabetic patients, 30 uremic type 1 diabetic patients, 27 uremic type 1 diabetic patients who had a kidney-pancreas transplant, 12 uremic type 1 diabetic patients who had a kidney-alone transplant, and 13 healthy control subjects. We evaluated platelet and clotting system. Platelets in the group of uremic type 1 diabetic patients were significantly larger than platelets in the other groups. Resting calcium levels were significantly higher in the uremic type 1 diabetic patients and uremic type 1 diabetic patients who had a kidney-alone transplant than in the type 1 diabetic patients who had a kidney-pancreas transplant and control subjects. CD41 expression was significantly reduced in platelets from the uremic type 1 diabetic patients compared with the other groups. Levels of hypercoagulability markers in the type 1 diabetic patients who had a kidney-pancreas transplant and, to a lesser extent, the uremic type 1 diabetic patients who had a kidney-alone transplant but not the uremic type 1 diabetic patients were similar to those of the control subjects. A reduction in natural anticoagulants was evident in the uremic type 1 diabetic patients, whereas near-normal values were observed in the type 1 diabetic patients who had a kidney-pancreas transplant and uremic type 1 diabetic patients who had a kidney-alone transplant. Hemostatic abnormalities were not observed in type 1 diabetic patients who had a kidney-pancreas transplant. This finding might explain the lower cardiovascular death rate observed in type 1 diabetic patients who had a kidney-pancreas transplant compared with uremic type 1 diabetic patients who had a kidney-alone transplant or uremic type 1 diabetic patients.
49
Protease-activated receptor 3 is a second thrombin receptor in humans
Hiroaki Ishihara, Andrew J. Connolly, Dewan Zeng et al. · Nature · 1997 · 875 citations
Philip M. Bath, R J Butterworth · Blood Coagulation & Fibrinolysis · 1996 · 767 citations
Medicine, Cardiology, Hematology +13
Prevention of Obesity and Insulin Resistance in Mice Lacking Plasminogen Activator Inhibitor 1
Li-Jun Ma, Su-Li Mao, Kevin Taylor et al. · Diabetes · 2004 · 399 citations · Full text
Treatment of Reflux Oesophagitis